Skip to content
KStart free
AI InfrastructureDefenseQuantumAll studies →

KYMR US Equity

Kymera Therapeutics, Inc.Health Care · Biological Products, (No Diagnostic Substances) · CIK 1815442 · FY ends Dec 31
$127.31
+5.93 (+4.89%)
USD · as of 2026-08-19 · marketstack
15 8-K filings · 3 13D · 10 13G
DateEventWhat happened / filerSource
2026-08-1413G/ASchedule 13G amendment — ≥5% beneficial owner (passive) · by PRICE T ROWE ASSOCIATES INC /MD/sec.gov ↗
2026-08-1313G/ASchedule 13G amendment — ≥5% beneficial owner (passive) · by Atlas Venture Fund X, L.P.sec.gov ↗
2026-08-058-K 2.02Results of operations and financial condition (earnings)earnings history (EARN) →sec.gov ↗
2026-07-278-K 7.01Regulation FD disclosuresec.gov ↗
2026-07-278-K 5.02Departure/election of directors or officers; compensationsec.gov ↗
2026-06-2613D/ASchedule 13D amendment — ≥5% beneficial owner (active intent) · by BIOTECHNOLOGY VALUE FUND L Psec.gov ↗
2026-06-258-K 8.01Other eventssec.gov ↗
2026-06-258-K 7.01Regulation FD disclosuresec.gov ↗
2026-06-248-K 5.07Submission of matters to a vote of security holderssec.gov ↗
2026-06-088-K 5.02Departure/election of directors or officers; compensationsec.gov ↗
2026-05-1513GSchedule 13G filed — ≥5% beneficial owner (passive) · by T. Rowe Price Investment Management, Inc.sec.gov ↗
2026-05-1513G/ASchedule 13G amendment — ≥5% beneficial owner (passive) · by WELLINGTON MANAGEMENT GROUP LLPsec.gov ↗
2026-05-0613G/ASchedule 13G amendment — ≥5% beneficial owner (passive) · by FMR LLCsec.gov ↗
2026-04-308-K 2.02Results of operations and financial condition (earnings)earnings history (EARN) →sec.gov ↗
2026-03-278-K 5.03Amendments to articles of incorporation or bylaws; fiscal year changesec.gov ↗
2026-03-2713G/ASchedule 13G amendment — ≥5% beneficial owner (passive) · by VANGUARD GROUP INCsec.gov ↗
2026-02-268-K 8.01Other eventssec.gov ↗
2026-02-268-K 1.02Termination of a material definitive agreementsec.gov ↗
2026-02-268-K 1.01Entry into a material definitive agreementsec.gov ↗
2026-02-268-K 2.02Results of operations and financial condition (earnings)earnings history (EARN) →sec.gov ↗
2026-02-1013G/ASchedule 13G amendment — ≥5% beneficial owner (passive) · by WELLINGTON MANAGEMENT GROUP LLPsec.gov ↗
2026-01-138-K 7.01Regulation FD disclosuresec.gov ↗
2026-01-138-K 2.02Results of operations and financial condition (earnings)earnings history (EARN) →sec.gov ↗
2026-01-0813G/ASchedule 13G amendment — ≥5% beneficial owner (passive) · by FMR LLCsec.gov ↗
2025-12-1513D/ASchedule 13D amendment — ≥5% beneficial owner (active intent) · by BIOTECHNOLOGY VALUE FUND L Psec.gov ↗
2025-12-1113D/ASchedule 13D amendment — ≥5% beneficial owner (active intent) · by BAKER BROS. ADVISORS LPsec.gov ↗
2025-12-108-K 8.01Other eventssec.gov ↗
2025-12-108-K 1.01Entry into a material definitive agreementsec.gov ↗
2025-12-088-K 7.01Regulation FD disclosuresec.gov ↗
2025-12-088-K 8.01Other eventssec.gov ↗
2025-12-088-K 7.01Regulation FD disclosuresec.gov ↗
2025-11-1413G/ASchedule 13G amendment — ≥5% beneficial owner (passive) · by PRICE T ROWE ASSOCIATES INC /MD/sec.gov ↗
2025-11-0513G/ASchedule 13G amendment — ≥5% beneficial owner (passive) · by FMR LLCsec.gov ↗
2025-11-048-K 2.02Results of operations and financial condition (earnings)earnings history (EARN) →sec.gov ↗
2025-09-038-K 7.01Regulation FD disclosuresec.gov ↗
2025-09-038-K 5.02Departure/election of directors or officers; compensationsec.gov ↗
Source: SEC EDGAR (public domain) · history starts 2025-09-03

Every row is a filed document, checked against its EDGAR index.